These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31686845)

  • 1. Lenvatinib combined nivolumab injection followed by extended right hepatectomy is a feasible treatment for patients with massive hepatocellular carcinoma: a case report.
    Chen X; Zhang Y; Zhang N; Ge Y; Jia W
    Onco Targets Ther; 2019; 12():7355-7359. PubMed ID: 31686845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy.
    Ohya Y; Hayashida S; Tsuji A; Kuramoto K; Shibata H; Setoyama H; Hayashi H; Kuriwaki K; Sasaki M; Iizaka M; Nakahara O; Inomata Y
    Surg Case Rep; 2020 Dec; 6(1):318. PubMed ID: 33301055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose PD-1 inhibitor combined with lenvatinib for preemptive treatment of recurrence after liver transplantation for hepatocellular carcinoma: Case report and literature review.
    Jin X; Zhang K; Fang T; Zeng X; Yan X; Tang J; Liang Z; Xie L; Zhao D
    Front Oncol; 2022; 12():951303. PubMed ID: 36119543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report.
    Chen Z; Chen Z; Fan W; Zou Y; Zhang Y; Shi N; Jin H
    World J Surg Oncol; 2023 Jan; 21(1):29. PubMed ID: 36721173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report.
    Yokoo H; Takahashi H; Hagiwara M; Iwata H; Imai K; Saito Y; Matsuno N; Furukawa H
    World J Hepatol; 2020 Dec; 12(12):1349-1357. PubMed ID: 33442460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report.
    Liu Z; Li X; He X; Xu Y; Wang X
    BMC Cancer; 2019 Nov; 19(1):1062. PubMed ID: 31703571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
    Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
    Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report.
    Zhu SG; Li HB; Yuan ZN; Liu W; Yang Q; Cheng Y; Wang WJ; Wang GY; Li H
    World J Gastrointest Oncol; 2020 Oct; 12(10):1209-1215. PubMed ID: 33133387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma.
    Wen S; Zeng J; Zhong L; Ye J; Lai X
    Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):53-57. PubMed ID: 37114307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual Techniques for Preserving Surgical and Oncologic Safety in Hepatectomy of Advanced Adrenal Malignancy with Vena Cava and Liver Invasion.
    Lee JM; Lee KW; Hong SK; Yoon KC; Cho JH; Yi NJ; Suh KS
    Ann Surg Oncol; 2018 Oct; 25(11):3324-3325. PubMed ID: 30019302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date.
    Tella SH; Mahipal A; Kommalapati A; Jin Z
    Onco Targets Ther; 2019; 12():10335-10342. PubMed ID: 31819517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Y-90 Radioembolization Combined with a PD-1 Inhibitor for Advanced Hepatocellular Carcinoma.
    Wehrenberg-Klee E; Goyal L; Dugan M; Zhu AX; Ganguli S
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1799-1802. PubMed ID: 29845347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion Hepatectomy for Huge Hepatocellular Carcinoma With Arterioportal Shunt After Chemoembolization and Lenvatinib Therapy.
    Sato N; Beppu T; Kinoshita K; Yuki H; Suyama K; Chiyonaga S; Motohara T; Komohara Y; Hara A; Akahoshi S
    Anticancer Res; 2019 Oct; 39(10):5695-5701. PubMed ID: 31570469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion surgery after lenvatinib treatment for multiple lung metastases from hepatocellular carcinoma.
    Sano S; Asahi Y; Kamiyama T; Kakisaka T; Orimo T; Nagatsu A; Aiyama T; Kazui K; Shomura H; Ueki S; Sakamoto Y; Shirakawa C; Kamachi H; Sugino H; Mitsuhashi T; Taketomi A
    Int Cancer Conf J; 2023 Jan; 12(1):7-13. PubMed ID: 36605836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options.
    Ghavimi S; Apfel T; Azimi H; Persaud A; Pyrsopoulos NT
    J Clin Transl Hepatol; 2020 Jun; 8(2):168-176. PubMed ID: 32832397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma.
    Liu Z; Lin Y; Zhang J; Zhang Y; Li Y; Liu Z; Li Q; Luo M; Liang R; Ye J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):447. PubMed ID: 31684985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma.
    Kotani K; Enomoto M; Okada M; Yoshida K; Motoyama H; Fujii H; Hagihara A; Uchida-Kobayashi S; Morikawa H; Murakami Y; Tamori A; Kawada N
    Clin J Gastroenterol; 2019 Aug; 12(4):355-360. PubMed ID: 31020569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma incidentally detected at second hepatectomy for repeated colorectal liver metastasis in a patient with hepatitis C virus-related cirrhosis: a case report.
    Kobayashi A; Morioka D; Matsumoto C; Miura Y; Miura M
    J Med Case Rep; 2016 May; 10(1):136. PubMed ID: 27234582
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.